Literature DB >> 26304253

Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department.

Michael D Brown, John H Burton, Devorah J Nazarian, Susan B Promes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26304253     DOI： 10.1016/j.annemergmed.2015.06.031

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN： 0196-0644            Impact factor:   5.721


× No keyword cloud information.
  11 in total

1.  Effects of increasing IV tPA-treated stroke mimic rates at CT-based centers on clinical outcomes.

Authors:  Tina M Burton; Marie Luby; Zurab Nadareishvili; Richard T Benson; John K Lynch; Lawrence L Latour; Amie W Hsia
Journal:  Neurology       Date:  2017-06-28       Impact factor: 9.910

2.  Getting the Gist Across Is Enough for Informed Consent for Acute Stroke Thrombolytics.

Authors:  Lesli E Skolarus; Alison O'Brien; William J Meurer; Brian J Zikmund Fisher
Journal:  Stroke       Date:  2019-05-14       Impact factor: 7.914

3.  18F-positron-emitting/fluorescent labeled erythrocytes allow imaging of internal hemorrhage in a murine intracranial hemorrhage model.

Authors:  Ye Wang; Fei-Fei An; Mark Chan; Beth Friedman; Erik A Rodriguez; Roger Y Tsien; Omer Aras; Richard Ting
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-05       Impact factor: 6.200

4.  Perceived Appropriateness of Shared Decision-making in the Emergency Department: A Survey Study.

Authors:  Marc A Probst; Hemal K Kanzaria; Dominick L Frosch; Erik P Hess; Gary Winkel; Ka Ming Ngai; Lynne D Richardson
Journal:  Acad Emerg Med       Date:  2016-03-22       Impact factor: 3.451

5.  Model-based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic stroke.

Authors:  Jinju Guk; Dongwoo Chae; Hankil Son; Joonsang Yoo; Ji Hoe Heo; Kyungsoo Park
Journal:  Br J Clin Pharmacol       Date:  2018-08-21       Impact factor: 4.335

Review 6.  An appraisal of emergency medicine clinical practice guidelines: Do we agree?

Authors:  Alyssa Zupon; Craig Rothenberg; Katherine Couturier; Ting-Xu Tan; Gina Siddiqui; Matthew James; Dan Savage; Edward R Melnick; Arjun K Venkatesh
Journal:  Int J Clin Pract       Date:  2018-11-14       Impact factor: 2.503

7.  Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances.

Authors:  Brian Scott Alper; Gary Foster; Lehana Thabane; Alex Rae-Grant; Meghan Malone-Moses; Eric Manheimer
Journal:  BMJ Evid Based Med       Date:  2020-05-19

8.  Citation bias favoring positive clinical trials of thrombolytics for acute ischemic stroke: a cross-sectional analysis.

Authors:  Benjamin S Misemer; Timothy F Platts-Mills; Christopher W Jones
Journal:  Trials       Date:  2016-09-28       Impact factor: 2.279

9.  Updated clinical guidelines experience major reporting limitations.

Authors:  Robin W M Vernooij; Laura Martínez García; Ivan Dario Florez; Laura Hidalgo Armas; Michiel H F Poorthuis; Melissa Brouwers; Pablo Alonso-Coello
Journal:  Implement Sci       Date:  2017-10-12       Impact factor: 7.327

10.  The predictive value of red cell distribution width for stroke severity and outcome.

Authors:  Kavous Shahsavarinia; Younes Ghavam Laleh; Payman Moharramzadeh; Mahboob Pouraghaei; Elyar Sadeghi-Hokmabadi; Fatemeh Seifar; Farid Hajibonabi; Zhila Khamnian; Mehdi Farhoudi; Sara Mafi
Journal:  BMC Res Notes       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.